Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma
Condition(s):Osteoid OsteomaLast Updated:February 23, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Osteoid OsteomaLast Updated:February 23, 2022Terminated
Condition(s):Pain; Bone Neoplasms; Neoplasm MetastasisLast Updated:January 22, 2014Completed
Condition(s):Pain; Bone Neoplasm; Neoplasm MetastasisLast Updated:August 16, 2017Withdrawn
Condition(s):Multiple MyelomaLast Updated:August 5, 2014Completed
Condition(s):Bone MetastasisLast Updated:April 4, 2017Terminated
Condition(s):Non-small Cell Lung Cancer; Bone MetastasisLast Updated:January 16, 2019Unknown status
Condition(s):Bone Pain; Metastatic Malignant Neoplasm in the Bone; Plasma Cell MyelomaLast Updated:March 28, 2024Recruiting
Condition(s):Bone MetastasisLast Updated:August 10, 2018Completed
Condition(s):Fibrous Dysplasia of BoneLast Updated:August 30, 2021Completed
Condition(s):Osteoarthritis; Arthritis, Rheumatoid; DyspepsiaLast Updated:August 24, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.